Abstract:BACKGROUND:Membranous nephropathy (MN) is mainly classified into idiopathic MN (iMN) and secondary MN in etiology. In recent years, a new kind of membranous nephropathy, atypical membranous nephropathy (aMN) which shows "full house" in immunofluorescence but without definite etiology was paid more attention. In a single center cohort, the renal outcomes of iMN and aMN were compared. METHODS:iMN and aMN patients were selected from renal pathology databank from January 2006 to December 2015. Patients' demographics, laboratory values, induction regimens and patients' responses were recorded. Specially, creatinine, eGFR, albumin and 24 h urinary protein excretion were recorded at 6th month after the induction of immunosuppressive (IS) treatment and at the end of follow up. Complete proteinuria remission was defined as urinary protein < 0.3 g/d, partial proteinuria remission was defined as urinary protein between 0.3 g/d ~ 3.5 g/d and decreased > 50 % from the baseline. The primary outcome was worsening renal function, defined as a 30 % or more decrease in eGFR or end-stage renal disease (eGFR < 15ml/min/1.73m2). COX proportional hazard models were used to test if aMN was a risk factor of worsening renal function compared with iMN. RESULTS:There were 298 patients diagnosed with MN and followed in our center for 1 year or more, including 145 iMN patients with an average follow-up time of 4.5 ± 2.6 years, and 153 aMN patients with 4.1 ± 2.0 years (p = 0.109). The average age of iMN patients was older than aMN patients (56.1 ± 12.2 versus 47.2 ± 16.2 years old, p < 0.001). There were 99 iMN patients and 105 aMN patients with nephrotic range proteinuria and without previous immunosuppressive treatment. 93 (93.9 %) and 95 (90.5 %) patients underwent immunosuppressive treatment in iMN and aMN group, and there was no significant difference of the overall proteinuria remission rates at 6th month (59.1 % vs. 52.0 %, p = 0.334) and endpoint (73.7 % vs. 69.5 %, p = 0.505) between the two groups. 25 (25.3 %) patients in iMN group and 21 (20.0 %) patients in aMN group reached primary endpoint (X2 = 0.056, p = 0.812). Multivariate COX regression showed that after demographics, baseline laboratory values and remission status at 6th month were adjusted, aMN group had similar renal outcome compared with iMN group, the HR of primary outcome was 0.735 (95 % CI 0.360 ~ 1.503, p = 0.399). CONCLUSIONS:The proteinuria remission rates and renal outcomes were similar in iMN and aMN patients after covariables were adjusted.

Concurrent membranous nephropathy and IgA nephropathy: a series of 55 cases

Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome? (vol 13, 846323, 2022)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.

Analysis of Clinical, Pathological and Prognostic Features of Coexistent Membranous and IgA Nephropathy in a Series of 13 Patients at a Tertiary Care Hospital

Clinical and Pathology Features of IgA Nephropathy with Active Tubular Interstitial Lesions

Clinical and Pathology Features of Idiopathic Membranous Nephropathy Accompanied by Mesangial Dense Deposit

[Two Cases Report and Literature Review of IgA Nephropathy Combined with Primary Membranous Nephropathy].

Clinical and Immunological Characteristics of Patients with Combined Anti-Glomerular Basement Membrane Disease and IgA Nephropathy.

Clinical and Immunologic Characteristics of Patients With ANCA-Associated Glomerulonephritis Combined With Membranous Nephropathy: A Retrospective Cohort Study in a Single Chinese Center.

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients

The Application of Podocyte Antigen PLA2R and Anti-Pla2r Antibody in the Diagnosis and Treatment of Membranous Nephropathy

Clinicopathological Analysis of IgA Nephropathy Combined with Other Glomerular Diseases

Antiphospholipid Antibodies in Patients with Membranous Nephropathy.

Clinical and Pathological Features of Patients with Antineutrophil Cytoplasmic Antibody‐associated Vasculitides Concomitant with IgG4‐related Disease

Renal Outcomes of Idiopathic and Atypical Membranous Nephropathy in Adult Chinese Patients: a Single Center Retrospective Cohort Study.

Clinical and Pathological Features of Anti-Glomerular Basement Membrane Disease Associated with Membranous Nephropathy: an Observational Study

Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study.

The Clinical and Immunological Features of Patients with Combined Anti-Glomerular Basement Membrane Disease and Membranous Nephropathy.

Clinicopathological Features of Idiopathic Membranous Nephropathy Combined with Iga Nephropathy: A Retrospective Analysis of 9 Cases

Clinicopathologic Features of Membranous Nephropathy Coexisting with IgA Nephropathy

Coexistence of Antineutrophil Cytoplasmic Antibody (Anca)-Associated Vasculitis (AAV) and IgA Nephropathy